Loading icon
HIF1A and the Biology of Progression in Multiple Sclerosis
HIF1A and the Biology of Progression in Multiple Sclerosis

This blog post examines a recent Acta Neuropathologica study showing that a protective genetic variant in HIF1A is associated with lower long-term disability accrual in multiple sclerosis and reduced markers of smoldering inflammation. It explains how the researchers combined genetics, MRI, neurofilament biomarkers, post-mortem pathology, single-nucleus RNA sequencing, and spatial transcriptomics to link this variant to smaller paramagnetic rim lesions, less axonal injury, lower iron-associated chronic inflammation, and cell-type-specific effects in myeloid populations at lesion rims. The article highlights why these findings matter for understanding progressive MS and for identifying new therapeutic targets aimed at slowing disease progression.

Read more